Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Molecular quality control are used to monitor the performance of testing procedure for viral load assay, healthcare associated infections and others. The molecular quality control produce include different control and validation support in the implementation and monitoring of assay which are majorly used by different clinical laboratories, hospitals for diagnosis. Besides, the rising pool of patient in infectious diseases, cancer, genetic disorders has significantly provided ample of growth opportunity for market. The growing geriatric population, changing lifestyle, burden of different diseases, rising research and development are some of the key factor driving the market growth.
The Asia Pacific market is driven by increasing number of accredited clinical laboratories across the region has contributed in the growth of market. Furthermore, growing adoption of third-party quality controls among the clinicians and physicians for diagnosis the disease like infectious diseases, cancer has further propelled the growth of market. Additionally, rising demand for external quality assessment support is the key factor accelerating the market growth. Similarly demand from end user for different molecular quality controls which can provide highest precision in the testing is the accelerating the market growth.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the Asia Pacific molecular quality controls market. In addition, complete analysis of changes on the Asia Pacific molecular quality controls market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 pandemic has provided a positive growth for market as number of laboratories were having increasing requirement molecular quality controls products.
The molecular quality controls market comprises of different market segment like product, analyte type, application, end users and country.
By product, the molecular quality controls market includes key segment of independent controls, instrument-specific controls. Instrument-specific Controls segment further includes PCR, DNA Sequencing & NGS and Other Technologies. Independent Controls is likely to emerge as market leading product segment in Asia Pacific molecular quality controls market as it helps in the laboratory to enhance the performance and assessment of sample testing process. Furthermore, the independent controls product provides uniformity in the sample testing. Also, instrument-specific controls is likely to witness emerging growth opportunity attributing to rising adoption of PCR and others which has led rising demand for instrument-specific controls in Asia Pacific region.
The molecular quality controls market, includes different analyte type like single-analyte controls, multi-analyte controls. Multi-analyte controls dominated Asia Pacific molecular quality controls market attributing to it helps to monitor the precision of sample assessment assays. Furthermore, multi-analyte controls cover wide range of formats and helps in quality control workflow and increasing confidence in results ultimately improving patient outcomes. Besides, rising adoption of single-analyte controls in molecular quality controls is expected to provide ample of growth opportunity for market.
The molecular quality controls market finds its major application in infectious diseases, oncology, genetic testing and others. Infectious diseases has register major market share in 2020 and the segment is likely to maintain its dominance over the forecast period. The region is known as the hot spot of emerging infectious disease which has led the rising requirement for molecular quality controls market. In addition, rising cases of COVID-19 in Asia Pacific’s different countries like India among others has propelled the growth of market. On the other hand, oncology is expected to witness increasing demand for market owing to rising incidence of cancer, growing awareness for diagnosis and treatment and rising number laboratories for cancer diagnosis has fuelled the growth of market.
The molecular quality controls market has different end user like clinical laboratories, hospitals, ivd manufacturers & cros, academic and research institutes. Clinical laboratories ideally have growing demand in Asia Pacific due to increasing incidence of diseases, where the laboratories constantly perform number of test for identifying and diagnosing the disease. Thereby occurrence of error in testing can significantly impact the overall result of testing, hence the molecular quality controls have increasing demand in the clinical laboratories. Furthermore, to provide the result with highest precision number of clinical laboratories are adopting the molecular quality controls products which is ultimately boosting the demand for market. Additionally, hospitals have rising demand for market products owing to diagnosis and early detection of disease. This features of market is expected to elevate the market at highest pace during the estimated time period.
Asia Pacific molecular quality controls market is studied for the following countries like China, India, Japan and Rest of APAC among others. The Asia Pacific market has rising demand for different molecular quality controls products owing to increasing burden of different infectious disease, cancer has led the demand for market. Furthermore, in Asia Pacific, China has register major market share and is expected to witness growth at highest pace during the estimated time period. For instance according to CDC, the top cause of death in China were estimated to be stroke, lung cancer , stomach cancer, Alzheimer’s disease, among other has fuel the demand for market. Also, the outbreak of COVID-19 has provided ample of growth opportunity for market. Additionally, India is expected to witness rapid growth during the estimated time period. The growing geriatric population, cancer burden and COVID-19 emerging cases has created a surge to implement the molecular quality controls products in the laboratories testing.
The key players in molecular quality controls market are Seracare Life Sciences Inc., Thermo Fisher Scientific, Bio-Rad Laboratories, Microbiologics Inc., Zeptometrix, Roche Diagnostics, Abbott Laboratories, Quidel, Qnostics and Maine Molecular Quality Controls Inc. among others.
March 2021: The Abbott Laboratories had announced U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the company's Alinity m Resp-4-Plex molecular assay to detect and differentiate SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) in one test. Alinity m uses Polymerase Chain Reaction (PCR) technology, which is known for its high sensitivity in detecting infectious diseases.
December 2020: Roche diagnostics had announced the launch of the cobas PIK3CA Mutation Test for patients with advanced or metastatic breast cancer. The cobas PIK3CA Mutation Test is a real-time PCR test for the qualitative detection and identification of 17 mutations in exons 2, 5, 8, 10, and 21 in the gene encoding the catalytic subunit of PIK3CA in DNA isolated from formalin-fixed paraffin-embedded tissue (FFPET).
May 2020: ZeptoMetrix had announced the development and release of a ready-to-use SARS-CoV-2 molecular quality control formulated with purified intact viral particles that have been chemically modified to render them non-infectious and refrigerator stable
July 2018: Quidel had announced that it received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its Solana Bordetella Complete Assay, a molecular diagnostic assay to be used with the Solana molecular diagnostic instrument for the qualitative detection and differentiation of Bordetella pertussis and Bordetella parapertussis nucleic acids isolated from nasopharyngeal swab specimens obtained from patients suspected of having a respiratory tract infection.
The report analyses the Asia Pacific molecular quality controls market based on by product, analyte type, application, end users and country. By product, the molecular quality controls market includes key segment of independent controls, instrument-specific controls. Independent Controls is likely to emerge as market leading product segment in Asia Pacific molecular quality controls market. The molecular quality controls market, includes different analyte type like single-analyte controls, multi-analyte controls. Multi-analyte controls dominated Asia Pacific molecular quality controls market. The molecular quality controls market finds its major application in infectious diseases, oncology, genetic testing and others. Infectious diseases has register major market share in 2020 and the segment is likely to maintain its dominance over the forecast period. The molecular quality controls market has different end user like clinical laboratories, hospitals, ivd manufacturers & cros, academic and research institutes. Clinical laboratories ideally have growing demand in Asia Pacific due to increasing incidence of diseases. Asia Pacific molecular quality controls market is studied for the following countries like China, India, Japan and Rest of APAC among others.
Why to buy this report:
